Prempro

According to recent reports, Wyeth faces between 3,600 and 5,500 lawsuits by women who say they were harmed by hormone therapy.

In midday trading, Wyeth's shares were at $45.31, down 17 cents, or 0.4 percent, on the New York Stock Exchange.

Costs associated with halting operations at the Rouses Point plant will be included in a third-quarter charge of 3 cents to 5 cents a share, previously announced, Wyeth said.

Wyeth last week said it expected to report third-quarter earnings of around 75 cents to 80 cents a share before items, topping Wall Street's estimate at the time, which called for earnings of 72 cents a share.

Subscribe to Newsday home delivery Health & Wellness Enter a Category View List Featu...

Read more...